(Q36736181)

16 August 2017

1 reference

title

Current status of bacterial resistance to third-generation cephalosporins (English)

1 reference

16 August 2017

main subject

antimicrobial resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730187

10 November 2022

author

Juan Luis Muñoz Bellido

3

object named as

J. L. Muñoz Bellido

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730187

10 November 2022

author name string

García-Rodríguez JA

1

1 reference

16 August 2017

García Sánchez JE

2

1 reference

16 August 2017

Muñoz Bellido JL

3

1 reference

16 August 2017

García García MI

4

1 reference

16 August 2017

J. A. García-Rodríguez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730187

10 November 2022

J. E. García Sánchez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730187

10 November 2022

M. I. García García

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730187

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1730187

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

16 August 2017

https://api.elsevier.com/content/article/PII:0732889392900582?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

https://api.elsevier.com/content/article/PII:0732889392900582?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Diagnostic Microbiology and Infectious Disease

10 November 2022

published in

1 reference

16 August 2017

volume

15

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

67-72

1 reference

Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species

16 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In vitro activity of HRE 664, a penem antibiotic.

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin.

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In-vitro studies of meropenem

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Antibacterial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Transferable resistance to extended-spectrum beta-lactams: a major threat or a minor inconvenience?

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

-Lactamase stability of cefotaxime

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Clinical importance of inducible beta-lactamases in gram-negative bacteria

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90058-2

10 November 2022

Identifiers

1 reference

16 August 2017

1 reference